Q32 Bio (QTTB) Total Current Liabilities (2017 - 2026)

Q32 Bio's Total Current Liabilities history runs 10 years deep, the most recent figure standing at $10.7 million for Q1 2026.

• In Q1 2026, Total Current Liabilities fell 26.82% year-over-year to $10.7 million; the TTM figure through Mar 2026 stood at $10.7 million (down 26.82% YoY), while the FY2025 annual figure was $11.3 million, down 31.09% from the prior year.
• Total Current Liabilities was $10.7 million for Q1 2026 at Q32 Bio, down from $11.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $33.0 million in Q1 2024 to a low of $10.7 million in Q1 2026.
• Historically, Total Current Liabilities has averaged $18.3 million across 5 years, with a median of $17.2 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities soared 78.06% in 2024, then sank 55.76% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $22.6 million in 2022, then sank by 37.5% to $14.1 million in 2023, then gained by 16.7% to $16.5 million in 2024, then plunged by 31.09% to $11.3 million in 2025, then dropped by 5.97% to $10.7 million in 2026.
• The last three Total Current Liabilities figures came in at $10.7 million (Q1 2026), $11.3 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.